Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126825702 | 12682570 | 2 | F | 20160830 | 20160825 | 20160905 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-092452 | BRISTOL MYERS SQUIBB | 45.00 | YR | M | Y | 0.00000 | 20160905 | CN | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126825702 | 12682570 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | Y | 21866 | SOLUTION FOR INJECTION | |||||||||
126825702 | 12682570 | 2 | SS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Intramuscular | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126825702 | 12682570 | 1 | Product used for unknown indication |
126825702 | 12682570 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126825702 | 12682570 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126825702 | 12682570 | Hypersensitivity | |
126825702 | 12682570 | Psychotic disorder | |
126825702 | 12682570 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |